ReviewCancer communications (London, England)2021

The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non-small cell lung cancer patients with epidermal growth factor receptor mutation.

Lin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.